Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × CTLA-4 Antigen × 1 year × Clear all

Sponsor

Conditions

Melanoma 13 Carcinoma, Renal Cell 10 Neoplasm Metastasis 6 Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Myelodysplastic Syndromes 4 Lung Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Transitional Cell 3 Brain Neoplasms 3 Uveal Melanoma 2 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Penile Neoplasms 2 Mycosis Fungoides 2 Meningioma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Histiocytoma, Malignant Fibrous 2 Glioblastoma 2

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡